๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease

โœ Scribed by Sally Chappell; Leslie Daly; Kevin Morgan; Tamar Guetta Baranes; Josep Roca; Roberto Rabinovich; Ann Millar; Seamas C. Donnelly; Vera Keatings; William MacNee; Jan Stolk; Pieter Hiemstra; Massimo Miniati; Simonetta Monti; Clare M. O'Connor; Noor Kalsheker


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
186 KB
Volume
27
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

โœฆ Synopsis


Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity worldwide. While cigarette smoking is a major cause of COPD, only 15% of smokers develop the disease, indicating major genetic influences. The most widely recognized candidate gene in COPD is SERPINA1, although it has been suggested that SERPINA3 may also play a role. To detect cryptic genetic variants that might contribute to disease, we identified 15 SNP haplotype tags from high-density SNP maps of the two genes and evaluated these SNPs in the largest case-control genetic study of COPD conducted so far. For SERPINA1, six newly identified haplotypes with a common backbone of five SNPs were found to increase the risk of disease by six- to 50-fold, the highest risk of COPD reported to date. In contrast, no haplotype associations for SERPINA3 were identified.


๐Ÿ“œ SIMILAR VOLUMES


One year administration of almitrine bis
โœ S. Stavchansky; J. T. Doluisio; C. M. MacLeod; M. B. Szalkowski; R. T. Bachand J ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 403 KB ๐Ÿ‘ 1 views

A double blind study utilizing orally administered almitrine bismesylate was conducted involving 36 stable chronic obstructive pulmonary disease (COPD) patients with hypoxia and with and without hypercapnia. The patients received 50 mg tablets twice daily for 360 days. Blood samples were taken both